Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Semcon in connection with the offer from Etteplan
Mandate

Vinge advises Semcon in connection with the offer from Etteplan

August 23, 2022 Capital Markets and Public M&A

Vinge has advised Semcon AB (publ) in connection with a public takeover offer provided by Etteplan Oyj to the shareholders of Semcon. The offer prices SEK 149 per share and values Semcon AB approximately SEK 2 699.

Vinge’s team primarily consists of Anders Strid, Erik Sjöman and Edin Agic as well as Anna Palmérus who is advising Semcon in connection with competition law issues. 

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026